Corvus Pharmaceuticals Stock Technical Analysis
| CRVS Stock | USD 3.38 0.00 0.00% |
As of the 28th of March, Corvus Pharmaceuticals shows the Mean Deviation of 3.65, standard deviation of 4.54, and Risk Adjusted Performance of (0.07). Corvus Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Corvus Pharmaceuticals information ratio and kurtosis to decide if Corvus Pharmaceuticals is priced correctly, providing market reflects its regular price of 3.38 per share. Given that Corvus Pharmaceuticals has information ratio of (0.09), we suggest you to validate Corvus Pharmaceuticals's prevailing market performance to make sure the company can sustain itself at a future point.
Corvus Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Corvus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to CorvusCorvus |
Corvus Pharmaceuticals Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 14.8 | Strong Buy | 6 | Odds |
Most Corvus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Corvus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Corvus Pharmaceuticals, talking to its executives and customers, or listening to Corvus conference calls.
Corvus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Corvus Pharmaceuticals Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Corvus Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Corvus Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for Corvus Pharmaceuticals. You can use it to identify possible trend reversals for Corvus Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Corvus Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Corvus Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Corvus Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.03 , which may suggest that Corvus Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 32.59, which is the sum of squared deviations for the predicted Corvus Pharmaceuticals price change compared to its average price change.About Corvus Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Corvus Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Corvus Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Corvus Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding Corvus Pharmaceuticals. By analyzing Corvus Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Corvus Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Corvus Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
Corvus Pharmaceuticals March 28, 2025 Technical Indicators
Most technical analysis of Corvus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Corvus from various momentum indicators to cycle indicators. When you analyze Corvus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.07) | |||
| Market Risk Adjusted Performance | 1.69 | |||
| Mean Deviation | 3.65 | |||
| Coefficient Of Variation | (1,112) | |||
| Standard Deviation | 4.54 | |||
| Variance | 20.64 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | 1.68 | |||
| Maximum Drawdown | 17.12 | |||
| Value At Risk | (7.53) | |||
| Potential Upside | 7.37 | |||
| Skewness | (0.22) | |||
| Kurtosis | 0.3472 |
Corvus Pharmaceuticals March 28, 2025 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Corvus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.25 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 3.75 | ||
| Day Typical Price | 3.62 | ||
| Price Action Indicator | (0.37) | ||
| Market Facilitation Index | 1.09 |
Additional Tools for Corvus Stock Analysis
When running Corvus Pharmaceuticals' price analysis, check to measure Corvus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corvus Pharmaceuticals is operating at the current time. Most of Corvus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Corvus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corvus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Corvus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.